You are here

  • Home
  • Archive
  • Volume 91, Issue 10
  • Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial

Article metrics

Article menu

Download PDFPDF

Epilepsy
Original research
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: August 2020 to August 2024

AbstractFullPdf
Aug 202011581132299
Sep 202018461833403
Oct 202011811154295
Nov 2020446431162
Dec 202010741044262
Jan 2021592555203
Feb 2021364360131
Mar 2021376361147
Apr 2021291287165
May 2021311305105
Jun 2021288289110
Jul 202124524176
Aug 202122721891
Sep 2021302290141
Oct 2021275264149
Nov 202127726179
Dec 202126926374
Jan 202223722899
Feb 202225026390
Mar 2022336326101
Apr 202223322396
May 202225224185
Jun 202225823968
Jul 202218817556
Aug 202224022574
Sep 202221319970
Oct 2022195182126
Nov 202217816083
Dec 202213113057
Jan 202313513677
Feb 2023227218115
Mar 202321120781
Apr 202318318482
May 202314513860
Jun 202315414856
Jul 202314913757
Aug 202313412583
Sep 202315014177
Oct 202313212958
Nov 202317217464
Dec 202313512250
Jan 20241047136
Feb 202414212166
Mar 2024187164142
Apr 202418316264
May 202413910942
Jun 202416015366
Jul 202420420260
Aug 202411710552
Total15396148255285